15-Deoxy- Δ12,14-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-γ-independent mechanism

Biochemical and Biophysical Research Communications

Volumn 302, Issue 2, 2003, Pages 415-420

  Hinz, Burkhard ^a   Brune, Kay ^a   Pahl, Andreas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

15 Deoxy 12,14 prostaglandin J2; Ciglitazone; Cyclooxygenase 2; Human blood monocytes; Peroxisome proliferator activated receptor ; Proinflammatory cytokines

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2,2 BIS(4 GLYCIDYLOXYPHENYL)PROPANE; 4,4' ISOPROPYLIDENEDIPHENOL; CIGLITAZONE; CYCLOOXYGENASE 2; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIRINIXIC ACID; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0037428314     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00195-5     Document Type: Article

References (24)

1. Tontonoz P., Hu E., Spiegelman B.M. Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell. 79:1994;1147-1156.
2. Brun R.P., Tontonoz P., Forman B.M., Ellis R., Chen J., Evans R.M., Spiegelman B.M. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev. 10:1996;974-984.
3. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P.et al. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
4. Lemberger T., Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signalling pathway in lipid physiology. Annu. Rev. Cell. Dev. Biol. 12:1996;335-363.
5. 2 is a ligand for the adipocyte determination factor PPAR γ Cell. 83:1995;803-812.
6. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation Cell. 83:1995;813-819.
7. Lehmann J.M., Moore L.B., Smith-Oliver T.A., Wilkison W.O., Willson T.M., Kliewer S.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR γ). J. Biol. Chem. 270:1995;12953-12956.
8. Willson T.M., Cobb J.E., Cowan D.J., Wiethe R.W., Correa I.D., Prakash S.R., Beck K.D., Moore L.B., Kliewer S.A., Lehmann J.M. The structure-activity relationship between peroxisome proliferator-activated receptor γ agonism and the antihyperglycemic activity of thiazolidinediones. J. Med. Chem. 39:1996;665-668.
9. Jiang C., Ting A.T., Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 391:1998;82-86.
10. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
11. 2 Proc. Natl. Acad. Sci. USA. 96:1999;4668-4673.
12. 2 in the regulation of microglial functions Eur. J. Neurosci. 12:2000;2215-2223.
13. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R.M. PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 7:2001;48-52.
14. Fahmi H., Di Battista J.A., Pelletier J.P., Mineau F., Ranger P., Martel-Pelletier J. Peroxisome proliferator-activated receptor γ activators inhibit interleukin-1β-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum. 44:2001;595-607.
15. 2 Biochem. Biophys. Res. Commun. 283:2001;750-755.
16. Rossi A., Kapahi P., Natoli G., Takahashi T., Chen Y., Karin M., Santoro M.G. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature. 403:2000;103-108.
17. Thieringer R., Fenyk-Melody J.E., Le Grand C.B., Shelton B.A., Detmers P.A., Somers E.P., Carbin L., Moller D.E., Wirght S.D., Berger J. Activation of peroxisome proliferator-activated receptor γ does not inhibit IL-6 or TNF-α responses of macrophages to lipopolysaccharide in vitro or in vivo. J. Immunol. 164:2000;1046-1054.
18. 2, but not troglitazone, modulates IL-1β effects in human chondrocytes by inhibiting NF-κB and AP-1 activation pathways FEBS Lett. 501:2001;24-30.
19. 2 and a peroxisome proliferator-activated receptor γ agonist on macrophage activation J. Leukoc. Biol. 69:2001;631-638.
20. 2 upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages Biochem. Biophys. Res. Commun. 272:2000;744-748.
21. 2 and nonsteroidal anti-inflammatory drugs Biochem. Biophys. Res. Commun. 278:2000;790-796.
22. 2 synthesis in murine macrophages Biochem. Biophys. Res. Commun. 274:2000;197-202.
23. Pahl A., Zhang M., Torok K., Kuss H., Friedrich U., Magyar Z., Szekely J., Horvath K., Brune K., Szelenyi I. Anti-inflammatory effects of a cyclosporine receptor-binding compound, D-43787. J. Pharmacol. Exp. Ther. 301:2002;738-746.
24. Wright H.M., Clish C.B., Mikami T., Hauser S., Yanagi K., Hiramatsu R., Serhan C.N., Spiegelman B.M. A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. J. Biol. Chem. 275:2000;1873-1877.